Internal Medicine, Hematology & Oncology · Baton Rouge, LA
NPI
1376761783
Since 2007
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
2
Medicare group memberships
Hospitals
2
Hospital affiliations
4950 Essen Lane
Baton Rouge, LA, 70809
Phone (225) 767-1311
Groups this clinician bills Medicare through
Medicare paid, 2024
$326K
25,438 services
Medicare patients, 2024
186
Average age 73
Drug cost, 2024
$2.7M
842 prescriptions
Company payments, 2025
$1,173
From 26 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Kellie D Schmeeckle was code J1100 (injection, dexamethasone sodium phosphate, 1 mg), 490 times for 21 patients. In total Kellie D Schmeeckle billed 25,438 services in 77 codes, and Medicare paid $326K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-04-07.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 490 | 21 | $0.09 | $44.23 |
| 99214 Office E&M - Established | Office | 160 | 72 | $83.61 | $13K |
| J2405 Injection, ondansetron hydrochloride, per 1 mg | Office | 124 | 11 | $0.07 | $9.13 |
| 99215 Office E&M - Established | Office | 113 | 39 | $127.68 | $14K |
| 99213 Office E&M - Established | Office | 62 | 50 | $54.65 | $3,388 |
| 96375 Injection Administration | Office | 60 | 21 | $10.82 | $649 |
| 96413 Chemotherapy Administration | Office | 33 | 20 | $88.24 | $2,912 |
| 96372 Injection Administration | Office | 33 | 20 | $10.43 | $344 |
| 96374 Injection Administration | Office | 29 | 19 | $25.84 | $749 |
| 96367 Intravenous Infusion, Hydration | Office | 23 | 11 | $20.13 | $463 |
By year: 2022 $1.0M for 62,700 services; 2023 $659K for 45,015 services; 2024 $326K for 25,438 services.
Medicare prescription drug claims, 2024
In 2024, the drug Kellie D Schmeeckle prescribed most often to Medicare patients was Anastrozole, with 150 prescriptions and refills. In total Kellie D Schmeeckle wrote 842 Medicare prescriptions that cost $2.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 150 | 382 | 40 | $3,391 |
| Tamoxifen Citrate Generic | 69 | 160 | 15 | $1,654 |
| Letrozole Generic | 47 | 107 | 11 | $850 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 44 | 44 | Under 11 | $1,594 |
| Escitalopram Oxalate Generic | 42 | 84 | Under 11 | $435 |
| Brukinsa Zanubrutinib | 26 | 26 | Under 11 | $393K |
| Tasigna Nilotinib Hcl | 26 | 26 | Under 11 | $507K |
| Jakafi Ruxolitinib Phosphate | 24 | 24 | Under 11 | $418K |
| Fentanyl Generic | 22 | 22 | Under 11 | $2,108 |
| Hydroxyurea Generic | 20 | 48 | Under 11 | $388 |
| Ibrance Palbociclib | 20 | 20 | Under 11 | $322K |
| Gabapentin Generic | 19 | 39 | Under 11 | $68.25 |
| Kisqali Ribociclib Succinate | 17 | 17 | Under 11 | $234K |
| Xarelto Rivaroxaban | 17 | 27 | Under 11 | $15K |
| Eliquis Apixaban | 16 | 22 | Under 11 | $12K |
Brand drugs: 228 claims; generic drugs: 614 claims; opioid claims: 105.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Kellie D Schmeeckle $1,173 ($1,173 in general payments such as food, travel and fees) from 26 companies. The largest payer was Daiichi Sankyo Inc. with $139.
| Company | Payments | Amount |
|---|---|---|
| Daiichi Sankyo Inc. 4568.T | 6 | $139 |
| Pfizer Inc. PFE | 5 | $113 |
| Celgene Corporation BMY | 6 | $113 |
| AstraZeneca Pharmaceuticals LP AZN | 5 | $90.3 |
| Janssen Biotech, Inc. JNJ | 3 | $72.82 |
| Novartis Pharmaceuticals Corporation NVS | 3 | $71.55 |
| Array Biopharma Inc PFE | 4 | $69.22 |
| Syndax Pharmaceuticals, Inc. SNDX | 2 | $50.51 |
| Jazz Pharmaceuticals Inc. JAZZ | 2 | $44.96 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 2 | $41.46 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.